Systemic adverse effects of ophthalmic β-blockers

Annals of Pharmacotherapy

Volumn 35, Issue 12, 2001, Pages 1633-1637

  Vander Zanden, Jeanne A ^a   Valuck, Robert J ^a   Bunch, Cheryl L ^b   Perlman, Jay I ^c   Anderson, Carolyn ^c   Wortman, George I ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UCHSC ^*

^c HINES VA HOSPITAL   (United States)

^d Applied Health Outcomes Pharmacia Inc   (United States)

Author keywords

Adverse effects; Ophthalmic solutions; adrenergic antagonists

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARTEOLOL; LEVOBUNOLOL; METIPRANOLOL; TIMOLOL;

ALOPECIA; ARTHROPATHY; ARTICLE; ASTHMA; BRADYCARDIA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFUSION; DEPRESSION; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; HALLUCINATION; HUMAN; HYPOGLYCEMIA; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; PSORIASIS; PSYCHOSIS; RESPIRATORY TRACT DISEASE; SEXUAL DYSFUNCTION; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HOSPITALS, VETERANS; HUMANS; OPHTHALMIC SOLUTIONS; RESPIRATORY SYSTEM; SKIN DISEASES; UNITED STATES;

EID: 0035666630     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18464     Document Type: Article

References (43)

1. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions
2. Methodology for assessing drug-drug interaction evidence in the peer-reviewed medical literature
3. Developing evidence-based clinical practice guidelines: Lessons learned by the US Preventive Services Task Force
4. The periodic health examination
5. Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections
6. Assessment of bronchial effects following topical administration of butylamino-phenoxy-propranol-acetate, an oculoselective betaadrenoreceptor blocker in asthmatic subjects
7. Effect of topical betaxolol, timolol and placebo on pulmonary function in asthmatic bronchitis
8. Bronchial and cardiovascular effects of ocular topical beta antagonists in asthmatic subjects: Comparison of timolol, carteolol and metipranolol
9. Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment of glaucoma
10. Betaxolol eye drops as a safe medication to lower intraocular pressure
11. Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases
12. Acute pulmonary edema associated with ocular metipranolol use
13. Prolonged severe hypercapnia complicating near fatal asthma in a 35-year-old woman
14. Timolol ophthalmic solution and respiratory arrest
15. Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient
16. Respiratory arrest following first dose of timolol ophthalmic solution
17. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma
18. Beta-blocker eyedrops and nocturnal arterial hypotension
19. Cardiac effects of topical timolol
20. Cardiopulmonary effects of timolol eyedrops
21. Bradycardia and congestive heart failure associated with ocular timolol maleate
22. Myocardial infarction after ophthalmic betaxolol
23. Syncope, bradycardia and atrioventricular block associated with topical ophthalmic levobunolol
24. Topical glaucoma medications and cardiovascular risk in the elderly
25. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker
26. Topical betablocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol
27. Effects of caneolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma
28. Topical timolol and serum lipoproteins
29. Effects of ocular betaxolol on glucose and lipid metabolism after long-term treatment
30. Timolol topically and diabetes mellitus
31. Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient
32. Lichen planus associated with topical beta-blocker therapy
33. Skin reactions due to eye drops: Report of two cases
34. Psoriasis induced by ophthalmic timolol preparations
35. Alopecia possibly secondary to topical ophthalmic beta-blockers
36. Sexual dysfunction secondary to topical ophthalmic timolol
37. Sexual dysfunction and ocular timolol
38. Severe nausea and vomiting with timolol eye drops
39. Topical timolol-induced arthropathy
40. Drug induced systemic lupus erythematosus due to ophthalmic timolol
41. A method for estimating the probability of adverse drug reactions
42. Users’ guides to the medical literature. IV. How to use an article about harm
43. Instruments for assessing the quality of drug studies published in the medical literature